Andrew R. Belch Department of Oncology University of Alberta Biography Publications Institution JoVE Articles Andrew R. Belch has not added a biography. If you are Andrew R. Belch and would like to personalize this page please email our Author Liaison for assistance. Publications Frequent Occurrence of Highly Expanded but Unrelated B-cell Clones in Patients with Multiple Myeloma PloS One. 2013 | Pubmed ID: 23724106 The Systemic Cytokine Environment is Permanently Altered in Multiple Myeloma PloS One. 2013 | Pubmed ID: 23544044 Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan As Drivers of Oncogenesis and Potential Drug Targets Current Cancer Drug Targets. May, 2013 | Pubmed ID: 23517594 Differential Nuclear Organization of Translocation-prone Genes in Nonmalignant B Cells from Patients with T(14;16) As Compared with T(4;14) or T(11;14) Myeloma Genes, Chromosomes & Cancer. Jun, 2013 | Pubmed ID: 23460268 Alteration of Introns in a Hyaluronan Synthase 1 (HAS1) Minigene Convert Pre-mRNA [corrected] Splicing to the Aberrant Pattern in Multiple Myeloma (MM): MM Patients Harbor Similar Changes PloS One. 2013 | Pubmed ID: 23301075 Impact of Age on Outcomes After Initial Therapy with Chemotherapy and Different Chemoimmunotherapy Regimens in Patients with Chronic Lymphocytic Leukemia: Results of Sequential Cancer and Leukemia Group B Studies Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2013 | Pubmed ID: 23233702 In Non-transplant Patients with Multiple Myeloma, the Pre-treatment Level of Clonotypic Cells Predicts Event-free Survival Molecular Cancer. 2012 | Pubmed ID: 23083101 In Multiple Myeloma, Bone-marrow Lymphocytes Harboring the Same Chromosomal Abnormalities As Autologous Plasma Cells Predict Poor Survival American Journal of Hematology. Jun, 2012 | Pubmed ID: 22495885 Differential Positioning and Close Spatial Proximity of Translocation-prone Genes in Nonmalignant B-cells from Multiple Myeloma Patients Genes, Chromosomes & Cancer. Aug, 2012 | Pubmed ID: 22489023 Expression, Adverse Prognostic Significance and Therapeutic Small Molecule Inhibition of Polo-like Kinase 1 in Multiple Myeloma Leukemia Research. Dec, 2011 | Pubmed ID: 21816470 In a Patient with Biclonal Waldenstrom Macroglobulinemia Only One Clone Expands in Three-dimensional Culture and Includes Putative Cancer Stem Cells Leukemia & Lymphoma. Feb, 2011 | Pubmed ID: 21133724 Multiple Myeloma May Include Microvessel Endothelial Cells of Malignant Origin Leukemia & Lymphoma. Apr, 2010 | Pubmed ID: 20233053 Promiscuity of Translocation Partners in Multiple Myeloma Journal of Cellular Biochemistry. Apr, 2010 | Pubmed ID: 20127714 Genetic Abnormalities in Waldenström's Macroglobulinemia Clinical Lymphoma & Myeloma. Mar, 2009 | Pubmed ID: 19362966 High Response Rate to Bortezomib with or Without Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: Results of a Global Phase 3b Expanded Access Program British Journal of Haematology. Jan, 2009 | Pubmed ID: 19036114 Altered Expression of Fibronectin and Collagens I and IV in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. Mar, 2009 | Pubmed ID: 19001640 Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells That Persist During Treatment with Rituximab Clinical Medicine. Oncology. 2008 | Pubmed ID: 21892289 Inherited and Acquired Variations in the Hyaluronan Synthase 1 (HAS1) Gene May Contribute to Disease Progression in Multiple Myeloma and Waldenstrom Macroglobulinemia Blood. Dec, 2008 | Pubmed ID: 18815290 Treatment of Relapsed and Refractory Myeloma Leukemia & Lymphoma. Aug, 2008 | Pubmed ID: 18608859 Analysis of Clonotypic Switch Junctions Reveals Multiple Myeloma Originates from a Single Class Switch Event with Ongoing Mutation in the Isotype-switched Progeny Blood. Sep, 2008 | Pubmed ID: 18577707 A Unique Three-dimensional Model for Evaluating the Impact of Therapy on Multiple Myeloma Blood. Oct, 2008 | Pubmed ID: 18535198 The Selective Aurora B Kinase Inhibitor AZD1152 is a Potential New Treatment for Multiple Myeloma British Journal of Haematology. Feb, 2008 | Pubmed ID: 18076711 Microfluidic Chips for Detecting the T(4;14) Translocation and Monitoring Disease During Treatment Using Reverse Transcriptase-polymerase Chain Reaction Analysis of IgH-MMSET Hybrid Transcripts The Journal of Molecular Diagnostics : JMD. Jul, 2007 | Pubmed ID: 17591936 Concordant but Not Discordant Bone Marrow Involvement in Diffuse Large B-cell Lymphoma Predicts a Poor Clinical Outcome Independent of the International Prognostic Index Blood. Aug, 2007 | Pubmed ID: 17475910 Molecular Characterization of Waldenstrom's Macroglobulinemia Reveals Frequent Occurrence of Two B-cell Clones Having Distinct IgH VDJ Sequences Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2007 | Pubmed ID: 17404080 Ten Years and Counting: So What Do We Know About T(4;14)(p16;q32) Multiple Myeloma Leukemia & Lymphoma. Nov, 2006 | Pubmed ID: 17107900 Understanding the Determinants of Exercise Intentions in Multiple Myeloma Cancer Survivors: an Application of the Theory of Planned Behavior Cancer Nursing. May-Jun, 2006 | Pubmed ID: 16783115 Impaired Class Switch Recombination (CSR) in Waldenstrom Macroglobulinemia (WM) Despite Apparently Normal CSR Machinery Blood. Apr, 2006 | Pubmed ID: 16317092 SSX Cancer Testis Antigens Are Expressed in Most Multiple Myeloma Patients: Co-expression of SSX1, 2, 4, and 5 Correlates with Adverse Prognosis and High Frequencies of SSX-positive PCs Journal of Immunotherapy (Hagerstown, Md. : 1997). Nov-Dec, 2005 | Pubmed ID: 16224274 Sensitive Detection Using Microfluidics Technology of Single Cell PCR Products from High and Low Abundance IgH VDJ Templates in Multiple Myeloma Journal of Immunological Methods. Oct, 2005 | Pubmed ID: 16150455 Potential Impact of a Single Nucleotide Polymorphism in the Hyaluronan Synthase 1 Gene in Waldenstrom's Macroglobulinemia Clinical Lymphoma. Mar, 2005 | Pubmed ID: 15794859 Origins of Waldenstrom's Macroglobulinemia: Does It Arise from an Unusual B-cell Precursor? Clinical Lymphoma. Mar, 2005 | Pubmed ID: 15794851 Intronic Splicing of Hyaluronan Synthase 1 (HAS1): a Biologically Relevant Indicator of Poor Outcome in Multiple Myeloma Blood. Jun, 2005 | Pubmed ID: 15731173 Receptor for Hyaluronan-mediated Motility Correlates with Centrosome Abnormalities in Multiple Myeloma and Maintains Mitotic Integrity Cancer Research. Feb, 2005 | Pubmed ID: 15705883 Overexpression of Transcripts Originating from the MMSET Locus Characterizes All T(4;14)(p16;q32)-positive Multiple Myeloma Patients Blood. May, 2005 | Pubmed ID: 15677557 Results of a Multicenter Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma After Autologous Stem Cell Transplant Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2004 | Pubmed ID: 15623591 Association Between Exercise and Quality of Life in Multiple Myeloma Cancer Survivors Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. Nov, 2004 | Pubmed ID: 15322968 RHAMM Expression and Isoform Balance Predict Aggressive Disease and Poor Survival in Multiple Myeloma Blood. Aug, 2004 | Pubmed ID: 15105292 Clonotypic IgM V/D/J Sequence Analysis in Waldenstrom Macroglobulinemia Suggests an Unusual B-cell Origin and an Expansion of Polyclonal B Cells in Peripheral Blood Blood. Oct, 2004 | Pubmed ID: 14764523 Abnormal Expression of Hyaluronan Synthases in Patients with Waldenstrom's Macroglobulimenia Seminars in Oncology. Apr, 2003 | Pubmed ID: 12720129 The Malignant Clone in Waldenstrom's Macroglobulinemia Seminars in Oncology. Apr, 2003 | Pubmed ID: 12720122 In Multiple Myeloma, T(4;14)(p16;q32) is an Adverse Prognostic Factor Irrespective of FGFR3 Expression Blood. Feb, 2003 | Pubmed ID: 12393535 Differential Expression of Human Equilibrative Nucleoside Transporter 1 (hENT1) Protein in the Reed-Sternberg Cells of Hodgkin's Disease Leukemia & Lymphoma. Jul, 2002 | Pubmed ID: 12389626 Clonotypic Myeloma Cells Able to Xenograft Myeloma to Nonobese Diabetic Severe Combined Immunodeficient Mice Copurify with CD34 (+) Hematopoietic Progenitors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2002 | Pubmed ID: 12374689 CD20-directed Serotherapy in Patients with Multiple Myeloma: Biologic Considerations and Therapeutic Applications Journal of Immunotherapy (Hagerstown, Md. : 1997). Jan-Feb, 2002 | Pubmed ID: 11924912 Leukemic B Cells Clonally Identical to Myeloma Plasma Cells Are Myelomagenic in NOD/SCID Mice Experimental Hematology. Mar, 2002 | Pubmed ID: 11882359 Intraclonal Homogeneity of Clonotypic Immunoglobulin M and Diversity of Nonclinical Post-switch Isotypes in Multiple Myeloma: Insights into the Evolution of the Myeloma Clone Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2002 | Pubmed ID: 11839670 דגם תרבות רקמות תלת ממדי למחקר עיקרי עצם אדם מח וממאיר שלו Mukti R. Parikh1, Andrew R. Belch2,3, Linda M Pilarski2,3, Julia Kirshner1 1Department of Biological Sciences, Purdue University, 2Department of Oncology, University of Alberta, 3Cross Cancer Institute JoVE 50947 Medicine
דגם תרבות רקמות תלת ממדי למחקר עיקרי עצם אדם מח וממאיר שלו Mukti R. Parikh1, Andrew R. Belch2,3, Linda M Pilarski2,3, Julia Kirshner1 1Department of Biological Sciences, Purdue University, 2Department of Oncology, University of Alberta, 3Cross Cancer Institute JoVE 50947 Medicine